BLACR
Bellevue Life Sciences Acquisition Corp. Rights
BLACR
BLACR
Delisted
BLACR was delisted on the 14th of February, 2025.
22 hedge funds and large institutions have $879K invested in Bellevue Life Sciences Acquisition Corp. Rights in 2023 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$54.2K | |
| 2 | +$43.5K | |
| 3 | +$43.5K | |
| 4 |
SFM
Spartan Fund Management
Toronto, Ontario,
Canada
|
+$40.1K |
| 5 |
ETH
Exos TFP Holdings
New York
|
+$34.8K |
Top Sellers
| 1 | -$28.9K | |
| 2 | -$22.5K | |
| 3 | -$3.99K | |
| 4 |
BI
Bulldog Investors
Saddle Brook,
New Jersey
|
-$356 |